A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019

被引：11
|
作者：
Shabani, M. [1 ]
Ehdaei, B. Sadegh [2 ]
Fathi, F. [3 ]
Dowran, R. [1 ]
机构：
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[2] Kashan Univ Med Sci, Fac Med, Microbiol & Immunol Dept, Kashan, Iran
[3] Isfahan Univ Med Sci, Sch Med, Dept Immunol, Esfahan, Iran
来源：
NEW MICROBES AND NEW INFECTIONS | 2021年 / 42卷
关键词：
COVID-19; daclatasvir; HCV; SARS-CoV-2; sofosbuvir; HEPATITIS-C VIRUS; HCV GENOTYPE 1; PLUS SOFOSBUVIR; LIVER-TRANSPLANTATION; VIRAL-HEPATITIS; INFECTION; EPIDEMIOLOGY; RESISTANCE; INHIBITOR; EFFICACY;
D O I：
10.1016/j.nmni.2021.100895
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Sofosbuvir and daclatasvir have been used successfully since 2013 for hepatitis C treatment. It has been shown by different studies that sofosbuvir can inhibit RNA polymerase of other positive-strand RNA viruses including Flaviviridae and Togaviridae. Homology between hepatitis C virus RNA polymerase and severe acute respiratory syndrome coronavirus 2 has also been established. The efficacy of sofosbuvir and daclatasvir as potential choices in treating patients with coronavirus disease 2019 and their recovery can be hypothesized. (c) 2021 The Authors. Published by Elsevier Ltd.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Treatment Outcomes for Patients Undergoing Hemodialysis with Chronic Hepatitis C on the Sofosbuvir and Daclatasvir Regimen
    Butt, Nazish
    Abbasi, Amanullah
    Khan, M. Ali
    Ali, Muhammad
    Mahesar, Ghulam B.
    Haleem, Farhan
    Manan, Abdul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [32] Current treatment options for leptospirosis: a mini-review
    Petakh, Pavlo
    Behzadi, Payam
    Oksenych, Valentyn
    Kamyshnyi, Oleksandr
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [33] Coronavirus disease 2019 and the liver
    Esteban, James Philip
    Sobotka, Lindsay
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 191 - 199
  • [34] Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir/sofosbuvir/ribavirin in the treatment of chronic hepatitis C
    Rivero-Juarez, Antonio
    Brieva, Teresa
    Frias, Mario
    Rivero, Antonio
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (09) : 901 - 910
  • [35] Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review
    Mucenic, Marcos
    de Melo Brandao, Ajacio Bandeira
    Marroni, Claudio Augusto
    Fleck Junior, Alfeu de Medeiros
    Zanotelli, Maria Lucia
    Leipnitz, Ian
    Meine, Mario Henrique
    Kiss, Guillermo
    Martini, Juliano
    Schlindwein, Eduardo Soares
    Costabeber, Ane Micheli
    Rodrigues Sacco, Fernanda Karlinsky
    Rossato, Giovana
    Cracco Cantisani, Guido Pio
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2019, 61
  • [36] Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
    McCreary, Erin K.
    Pogue, Jason M.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (04):
  • [37] Traditional Chinese medicine for treatment of coronavirus disease 2019: a review
    Cui, Huan-Tian
    Li, Yu-Ting
    Guo, Li-Ying
    Liu, Xiang-Guo
    Wang, Lu-Shan
    Jia, Jian-Wei
    Liao, Jia-Bao
    Miao, Jing
    Zhang, Zhai-Yi
    Wang, Li
    Wang, Hong-Wu
    Wen, Wei-Bo
    TRADITIONAL MEDICINE RESEARCH, 2020, 5 (02): : 65 - 73
  • [38] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [39] Chest Radiograph (CXR) Manifestations of the Novel Coronavirus Dis-ease 2019 (COVID-19): A Mini-review
    Chan, Wai Yee
    Hamid, Marlina Tanty Ramli
    Gowdh, Nadia Fareeda Muhammad
    Rahmat, Kartini
    Yaakup, Nur Adura
    Chai, Chee Shee
    CURRENT MEDICAL IMAGING, 2021, 17 (06) : 677 - 685
  • [40] Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons
    Mastrorosa, Ilaria
    Tempestilli, Massimo
    Notari, Stefania
    Lorenzini, Patrizia
    Fabbri, Gabriele
    Grilli, Elisabetta
    Bellagamba, Rita
    Vergori, Alessandra
    Cicalini, Stefania
    Ammassari, Adriana
    Agrati, Chiara
    Antinori, Andrea
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2022, 47 (01) : 135 - 142
12345